This week on the "Readout LOUD" podcast: the sudden withdrawal of a CDC nominee and what went wrong with Covid policies.

Shares of Nektar Therapeutics (NASDAQ:NKTR) added ~9% in the premarket on Friday after Oppenheimer upgraded the biopharma to ...

With this circuit, CEA-Leti demonstrated 4- and 16-point QAM, that increases the possible number of multiplexed devices by ...